BSPM [Biostar Pharmaceuticals,] DEF 14A: (Original Filing)

[SCHEDULE 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, Inc. _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies: ______________________________________ (2) Aggregate number of securities to which transaction applies: ______________________________________ (3) (4) Proposed maximum aggregate value of transaction: ______________________________________]

By | 2016-03-03T11:46:24+00:00 September 21st, 2012|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] DEF 14A: SCHEDULE 14A x o Check the appropriate box:

[SCHEDULE 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, Inc. _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies: ______________________________________ (2) Aggregate number of securities to which transaction applies: ______________________________________ (3) (4) Proposed maximum aggregate value of transaction: ______________________________________]

By | 2016-03-03T11:47:20+00:00 September 21st, 2012|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL] DEF 14A: (Original Filing)

[Skystar Bio-Pharmaceuticalmpany Notice of Annual Meeting and Proxy Statement Annual Meeting to be held on October 25, 2012, at 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District, Xian, Shaanxi Province, P.R. China, at 7:45 pm, local timeystar Bio-Pharmaceuticalmpany NOTICE OF ANNUAL MEETING OF SHAREHOLDERS Dear Shareholder:]

By | 2016-02-05T03:06:00+00:00 September 21st, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] DEF 14A: SCHEDULE 14A x o Check the appropriate box:

[SCHEDULE 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies:______________________________________ (2)gregate number of securities to which transaction applies:______________________________________ (3) (4) Proposed maximumgregate value of transaction: ______________________________________]

By | 2016-02-07T15:41:26+00:00 September 21st, 2012|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q/A: (Original Filing)

[Explanatory Note No. 31.1 * 31.2 * 32.1 * 32.2 * 101.INS** XBRL Instance Document 101.SCH** XBRL Taxonomy Extensionhema Document 101.CAL** XBRL Taxonomy Extensionlculation Linkbase Document 101.DEF** XBRL Taxonomy Extension Definition Linkbase Document 101.LAB** XBRL Taxonomy Extension Labels Linkbase Document 101.PRE** XBRL Taxonomy Extension Presentation Linkbase DocumentYSTARBIO-PHARMACEUTICALCOMPANY September 13, 2012]

By | 2016-02-05T03:07:50+00:00 September 13th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q/A: Explanatory Note No. 31.1 * 31.2 * 32.1

[Explanatory Note No. 31.1 * 31.2 * 32.1 * 32.2 * 101.INS** XBRL Instance Document 101.SCH** XBRL Taxonomy Extensionhema Document 101.CAL** XBRL Taxonomy Extensionlculation Linkbase Document 101.DEF** XBRL Taxonomy Extension Definition Linkbase Document 101.LAB** XBRL Taxonomy Extension Labels Linkbase Document 101.PRE** XBRL Taxonomy Extension Presentation Linkbase DocumentYSTARBIO-PHARMACEUTICALCOMPANY September 13, 2012]

By | 2016-02-05T03:08:43+00:00 September 13th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] S-8: (Original Filing)

[FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang President and Chief Executive Officer No. 588 Shiji Xi Avenue] [Biostar Pharmaceuticals, Inc. 2011 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2011 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Cozen O’Connor Letterhead] August 16, 2012 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 Re: Registration Statement on Form S-8 Very truly yours, EX-5 3 ex5-1.htm] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 of Biostar Pharmaceuticals, Inc. of our report dated March 27, 2012 relating to the consolidation financial statements, which appears in the Annual Report on Form 10-K of Biostar Pharmaceuticals,]

By | 2016-03-03T11:49:22+00:00 August 17th, 2012|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar